---
granola_id: 01db5bec-931e-46e9-83b2-adb76152074c
title: "Yosemite / Virtue"
type: note
created: 2025-09-05T16:34:45.010Z
updated: 2025-09-15T14:01:59.909Z
attendees:
  - lauren@yosemite.co
  - matt@yosemite.co
  - kunal@yosemite.co
  - sd@virtuevc.com
---
### Yosemite Overview

- Fund based in SF with therapeutic focus area
	- Started from Jobs family office 10 years ago, led by Reed Jobs
	- Cancer focus drives healthcare lens across investments
	- 80% general platform tech in healthcare system
	- Oncology frontier experience in data, interop, healthcare AI
- Early stage fund: seed through Series B
	- $2-10M check sizes depending on stage
	- Lead/co-lead/syndicate flexible approach
- Kunal and Matt met Aaron several months ago
	- Lauren came from payer space, re-examining payer digital transformation needs
	- Early in understanding what health plans want for digital transformation

### Aaron & Coco Assessment

- Domain expertise stands out significantly
	- Aaron: rare understanding of healthcare data flows, ETL, benchmarking
	- Can’t learn this tribal knowledge through AI or automation
	- Coco impressive in community meetups, breaking down complex claims concepts simply
- Commercial development trajectory
	- Initial concern about commercial muscle vs technical expertise
	- Aaron built sales skills over 12-18 months, now “pretty damn good”
	- Sold MultiCare enterprise deal directly
	- 75% of current ~$4M run rate captured in last 12 months
	- Multiple people asking to join Tuva just to sell the product
- Open source strategy very intentional
	- Purposeful approach vs closed-loop consulting model
	- Building massive business, not just $5-10M consulting revenue

### Market Position & Competitive Dynamics

- User adoption vs investor awareness gap
	- Deeply known among data engineers/scientists at health systems
	- Not well appreciated by investor community yet
	- Vocal unpaid ambassadors at Humana, Oscar, health systems
- Bottoms-up to enterprise motion proven
	- Data engineers join community → love product → drive C-suite adoption
	- MultiCare example: Azure shop implementing Tuva, evaluating Databricks vs Snowflake
	- Hybrid build/buy model vs traditional bifurcation
- Competitive advantages over Innovacer
	- Build vs buy era largely over - Tuva offers hybrid approach
	- Data engineers want control, transparency Tuva provides
	- Platform built over 2 years with continuous dogfooding
	- Natural language SQL capability on roadmap (3-year timeline)

### Growth Strategy & Future Opportunities

- Next phase: formal go-to-market investment
	- Hiring proven Milliman-style enterprise sellers
	- Building dedicated BD, revenue, customer success functions
	- Moving beyond organic word-of-mouth growth
- Multi-pronged approach planned
	- Continue open source community growth
	- Direct enterprise sales function
	- Managed services expansion beyond data transformation
- Biopharma expansion potential
	- Same data models as pop health analytics
	- Early proof with Adaptive Biotech data marts
	- Grav (former Chief Data Officer) advising on strategy
	- Advantage over $200M/year data acquisition models like Komodo
- Churn risk mitigation
	- Similar to Innovacer’s data activation → layered solutions approach
	- Quick dependency creation observed across portfolio
	- Attractive net revenue retention in healthcare buyers

Chat with meeting transcript: https://notes.granola.ai/d/01db5bec-931e-46e9-83b2-adb76152074c
